Try the Demo today!
| SEC Filing | Company/Stock | Trade Date | Transaction | Shares | Avg. Price | Total | % Holdings | Gain/Loss |
|---|---|---|---|---|---|---|---|---|
| 09-Oct-24 4:11 PM View:  | Sana Biotechnology, Inc. (SANA) | 07-Oct-24 | Grant | 5,938 | -- | -- | < 1% 5.78M to 5.79M | |
| 08-Jul-24 4:32 PM View: | Sana Biotechnology, Inc. (SANA) | 05-Jul-24 | Grant | 4,911 | -- | -- | < 1% 5.78M to 5.78M | |
| 08-Apr-24 4:51 PM View: | Sana Biotechnology, Inc. (SANA) | 05-Apr-24 | Grant | 2,774 | -- | -- | < 1% 5.78M to 5.78M | |
| 19-Mar-24 6:18 PM View: | Agilent Technologies Inc. (A) | 15-Mar-24 | Grant | 2,428 | $147.48 | $358,081.00 | 11% 22.55K to 24.98K | (2%) |
| 08-Jan-24 5:38 PM View: | Sana Biotechnology, Inc. (SANA) | 05-Jan-24 | Grant | 4,901 | -- | -- | < 1% 5.77M to 5.78M | |
| 06-Oct-23 4:20 PM View: | Sana Biotechnology, Inc. (SANA) | 05-Oct-23 | Grant | 6,925 | -- | -- | < 1% 5.77M to 5.77M | |
| 06-Jul-23 4:21 PM View: | Sana Biotechnology, Inc. (SANA) | 05-Jul-23 | Grant | 4,152 | -- | -- | < 1% 5.76M to 5.77M | |
| 06-Apr-23 4:45 PM View: | Sana Biotechnology, Inc. (SANA) | 05-Apr-23 | Grant | 7,716 | -- | -- | < 1% 5.75M to 5.76M | |
| 20-Mar-23 9:38 PM View: | Agilent Technologies Inc. (A) | 16-Mar-23 | Grant | 2,399 | $136.82 | $328,231.00 | 12% 19.98K to 22.38K | 6% |
| 06-Jan-23 4:17 PM View: | Sana Biotechnology, Inc. (SANA) | 05-Jan-23 | Grant | 6,702 | -- | -- | < 1% 5.75M to 5.75M | |
| 06-Oct-22 4:05 PM View: | Sana Biotechnology, Inc. (SANA) | 05-Oct-22 | Grant | 4,012 | -- | -- | < 1% 5.74M to 5.75M | |
| 09-Sep-22 4:05 PM View: | Lyell Immunopharma, Inc. (LYEL) | 08-Sep-22 | Option Exercise | 145,380 | $0.10 | $14,538.00 | 3% 4.54M to 4.69M | |
| 07-Jul-22 4:32 PM View: | Sana Biotechnology, Inc. (SANA) | 05-Jul-22 | Grant | 3,328 | -- | -- | < 1% 5.74M to 5.74M | |
| 06-Apr-22 5:55 PM View: | Sana Biotechnology, Inc. (SANA) | 05-Apr-22 | Grant | 2,880 | -- | -- | < 1% 5.74M to 5.74M | |
| 21-Mar-22 5:03 PM View: | Agilent Technologies Inc. (A) | 17-Mar-22 | Grant | 2,582 | $136.82 | $353,269.00 | 15% 17.27K to 19.85K | 6% |
| 25-Feb-22 4:05 PM View: | Lyell Immunopharma, Inc. (LYEL) | 23-Feb-22 | Option Exercise | 993,428 | $0.10 | $99,342.80 | 28% 3.55M to 4.54M | |
| 23-Jun-21 5:35 PM View: | Lyell Immunopharma, Inc. (LYEL) | 21-Jun-21 | Conversion | 546,806 | -- | -- | 18% 3.0M to 3.55M | |
| 22-Mar-21 3:14 PM View: | Agilent Technologies Inc. (A) | 18-Mar-21 | Grant | 2,672 | $121.59 | $324,896.00 | 18% 14.5K to 17.18K | < 1% |
| 10-Feb-21 7:00 PM View: | Sana Biotechnology, Inc. (SANA) | 08-Feb-21 | Conversion | 2,031,250 | -- | -- | 55% 3.71M to 5.74M | |
| 05-Aug-20 6:30 PM View: | Agilent Technologies Inc. (A) | 03-Aug-20 | Grant | 177 | $93.91 | $16,622.10 | 1% 14.28K to 14.46K | |
| 21-Apr-20 7:32 PM View: | Agilent Technologies Inc. (A) | 17-Apr-20 | Grant | 4,108 | $73.01 | $299,921.00 | 41% 10.12K to 14.23K | (4%) |
| 22-Nov-19 7:30 AM View: | Celgene Corporation (CELG) | 20-Nov-19 | Disposition | 23,088 | -- | -- | (100%) 23.09K to 0 | |
| 22-Mar-19 2:20 PM View: | Agilent Technologies Inc. (A) | 21-Mar-19 | Grant | 3,450 | $82.00 | $282,936.00 | 52% 6.58K to 10.03K | 0% |
| 23-Mar-18 6:27 PM View: | Agilent Technologies Inc. (A) | 22-Mar-18 | Grant | 4,314 | $67.47 | $291,070.00 | 195% 2.21K to 6.52K | |
| 07-Mar-18 6:15 PM View: | Juno Therapeutics, Inc. (JUNO) | 05-Mar-18 | Disposition | 184,281 | $23.05 | $4,248,120.00 | (8%) 2.45M to 2.26M | |
| 07-Mar-18 6:15 PM View: | Juno Therapeutics, Inc. (JUNO) | 05-Mar-18 | Disposition (change in control) | 2,263,950 | $87.00 | $196,963,008.00 | (100%) 2.26M to 0 | |
| 09-Feb-18 7:29 PM View: | Juno Therapeutics, Inc. (JUNO) | 07-Feb-18 | Payment of Exercise | 4,346 | $85.49 | $371,540.00 | (< 1%) 2.57M to 2.56M | |
| 09-Feb-18 7:29 PM View: | Juno Therapeutics, Inc. (JUNO) | 07-Feb-18 | Gift | 116,280 | -- | -- | (5%) 2.56M to 2.45M | |
| 02-Feb-18 7:28 PM View: | Juno Therapeutics, Inc. (JUNO) | 31-Jan-18 | Grant | 66,426 | -- | -- | 3% 2.5M to 2.57M | |
| 18-Jan-18 9:30 PM View: | Juno Therapeutics, Inc. (JUNO) | 16-Jan-18 | Option Exercise | 245,750 | $6.36 | $1,562,970.00 | 10% 2.53M to 2.77M | |
| 18-Jan-18 9:30 PM View: | Juno Therapeutics, Inc. (JUNO) | 16-Jan-18 | Market Option Sale | 245,750 | $46.17 | $11,347,300.00 | (9%) 2.77M to 2.53M | |
| 18-Jan-18 9:30 PM View: | Juno Therapeutics, Inc. (JUNO) | 16-Jan-18 | Market Sale | 24,500 | $46.17 | $1,131,260.00 | (< 1%) 2.53M to 2.5M | |
| 20-Oct-17 8:25 PM View: | Juno Therapeutics, Inc. (JUNO) | 20-Oct-17 | Grant | 35,893 | -- | -- | 1% 2.49M to 2.53M | |
| 18-Jul-17 6:29 PM View: | Agilent Technologies Inc. (A) | 18-Jul-17 | Grant | 2,199 | $61.21 | $134,601.00 | 100% 0 to 2.2K | |
| 09-Feb-17 7:33 PM View: | Juno Therapeutics, Inc. (JUNO) | 07-Feb-17 | Grant | 44,177 | -- | -- | 2% 2.45M to 2.49M | |
| 29-Sep-16 6:02 PM View: | Juno Therapeutics, Inc. (JUNO) | 27-Sep-16 | Option Exercise | 44,000 | $6.36 | $279,840.00 | 2% 2.45M to 2.49M | |
| 29-Sep-16 6:02 PM View: | Juno Therapeutics, Inc. (JUNO) | 27-Sep-16 | Market Option Sale | 44,000 | $33.00 | $1,452,000.00 | (2%) 2.49M to 2.45M | (222%) |
| 21-Sep-16 7:34 PM View: | Juno Therapeutics, Inc. (JUNO) | 21-Sep-16 | Option Exercise | 6,057 | $6.36 | $38,522.50 | < 1% 2.52M to 2.52M | |
| 21-Sep-16 7:34 PM View: | Juno Therapeutics, Inc. (JUNO) | 21-Sep-16 | Market Option Sale | 6,057 | $30.30 | $183,542.00 | (< 1%) 2.52M to 2.52M | (251%) |
| 21-Sep-16 7:34 PM View: | Juno Therapeutics, Inc. (JUNO) | 21-Sep-16 | Market Sale | 71,250 | $30.30 | $2,159,050.00 | (3%) 2.52M to 2.45M | (251%) |
| 21-Sep-16 7:34 PM View: | Juno Therapeutics, Inc. (JUNO) | 20-Sep-16 | Option Exercise | 6,300 | $6.36 | $40,068.00 | < 1% 2.52M to 2.52M | |
| 21-Sep-16 7:34 PM View: | Juno Therapeutics, Inc. (JUNO) | 20-Sep-16 | Market Option Sale | 6,300 | $30.00 | $189,003.00 | (< 1%) 2.52M to 2.52M | (254%) |
| 21-Sep-16 7:34 PM View: | Juno Therapeutics, Inc. (JUNO) | 19-Sep-16 | Option Exercise | 428 | $6.36 | $2,722.08 | < 1% 2.52M to 2.52M | |
| 21-Sep-16 7:34 PM View: | Juno Therapeutics, Inc. (JUNO) | 19-Sep-16 | Market Option Sale | 428 | $30.00 | $12,840.00 | (< 1%) 2.52M to 2.52M | (254%) |
| 09-Sep-16 8:07 PM View: | Juno Therapeutics, Inc. (JUNO) | 08-Sep-16 | Option Exercise | 23,042 | $6.36 | $146,547.00 | < 1% 2.52M to 2.54M | |
| 09-Sep-16 8:07 PM View: | Juno Therapeutics, Inc. (JUNO) | 08-Sep-16 | Market Option Sale | 23,042 | $30.06 | $692,578.00 | (< 1%) 2.54M to 2.52M | (253%) |
| 02-Sep-16 8:37 PM View: | Juno Therapeutics, Inc. (JUNO) | 31-Aug-16 | Option Exercise | 18,173 | $6.36 | $115,580.00 | < 1% 2.54M to 2.56M | |
| 02-Sep-16 8:37 PM View: | Juno Therapeutics, Inc. (JUNO) | 31-Aug-16 | Market Option Sale | 18,173 | $30.06 | $546,197.00 | (< 1%) 2.56M to 2.54M | (254%) |
| 02-Sep-16 8:37 PM View: | Juno Therapeutics, Inc. (JUNO) | 31-Aug-16 | Market Sale | 24,500 | $30.06 | $736,357.00 | (< 1%) 2.54M to 2.52M | (254%) |
| 01-Jul-16 8:36 PM View: | Juno Therapeutics, Inc. (JUNO) | 30-Jun-16 | Disposition | 115,250 | $38.45 | $4,431,120.00 | (4%) 2.66M to 2.54M | (176%) |